Literature DB >> 28339024

Effects of berberine on a rat model of chronic stress and depression via gastrointestinal tract pathology and gastrointestinal flora profile assays.

Xiaohui Zhu1, Yangdong Sun2, Chenggang Zhang3, Haifeng Liu1.   

Abstract

Chronic stress and depression are challenging conditions to treat, owing to their complexity and lack of clinically available and effective therapeutic agents. The aim of the present study was to investigate the mechanism by which berberine acts, by examining alterations to gastrointestinal tract histopathology and flora profile in a rat model, following the induction of stress. Research associating gastrointestinal flora and depression has increased, thus, the present study hypothesized that stress induces depression and changes in the gastrointestinal system. The chronic mild stress rat model was previously established based on a set of 10 chronic unpredictable stress methods. In the present study, the measurements of body weight, behavior, gastrointestinal tract histopathology and gastrointestinal flora profile were collected in order to elucidate understanding of chronic stress and depression in this region. In the present study, induced stress and the resulting depression was demonstrated to significantly decrease the body weight and sucrose preference of rats, as well as significantly increasing traverse time, vertical movement time, grooming time and motionless time in an open‑field test. Following modeling and subsequent treatment with low or high doses of berberine, the measurements were significantly different when compared with unstressed rats. Berberine appears to reverse the physical damage brought about by stress within the gastric mucosa and intestinal microvilli of the stomach, ileum, cecum and colon. Using enterobacterial repetitive intergenic consensus sequence‑based polymerase chain reaction analysis, several distinctive bands disappeared following modeling; however, novel distinctive bands appeared in response to the graded berberine treatment. In conclusion, the present study identified that high concentrations of berberine markedly protects rats from various symptoms of chronic stress and depression, with the potential of facilitating treatment within clinical practice.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28339024     DOI: 10.3892/mmr.2017.6353

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

Review 1.  Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases.

Authors:  Shruti Mishra; Sumit S Verma; Vipin Rai; Nikee Awasthee; Srinivas Chava; Kam Man Hui; Alan Prem Kumar; Kishore B Challagundla; Gautam Sethi; Subash C Gupta
Journal:  Cell Mol Life Sci       Date:  2019-03-16       Impact factor: 9.261

2.  Improvement of adjunctive berberine treatment on negative symptoms in patients with schizophrenia.

Authors:  Meijuan Li; Yuying Qiu; Jing Zhang; Yonghui Zhang; Ying Liu; Yongping Zhao; Qiong Jia; Xiaoduo Fan; Jie Li
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-01-17       Impact factor: 5.270

3.  Uncovering the Potential Mechanisms of Coptis chinensis Franch. for Serious Mental Illness by Network Pharmacology and Pharmacology-Based Analysis.

Authors:  Yiyu Qi; Saijia Ni; Xia Heng; Shuyue Qu; Pingyuan Ge; Xin Zhao; Zengying Yao; Rui Guo; Nianyun Yang; Qichun Zhang; Huaxu Zhu
Journal:  Drug Des Devel Ther       Date:  2022-02-09       Impact factor: 4.162

Review 4.  Molecular Mechanisms Associated with Antidepressant Treatment on Major Depression.

Authors:  Lívia Ramos-da-Silva; Pamela T Carlson; Licia C Silva-Costa; Daniel Martins-de-Souza; Valéria de Almeida
Journal:  Complex Psychiatry       Date:  2021-07-09

5.  Gut Microbiota Are Associated With Psychological Stress-Induced Defections in Intestinal and Blood-Brain Barriers.

Authors:  Shaohui Geng; Liping Yang; Feng Cheng; Zhumou Zhang; Jiangbo Li; Wenbo Liu; Yujie Li; Yukun Chen; Yu Bao; Lin Chen; Zihao Fei; Xinmin Li; Junlin Hou; Yuan Lin; Zhilin Liu; Shuai Zhang; Hengtao Wang; Qing Zhang; Honggang Wang; Xiaodan Wang; Jingtao Zhang
Journal:  Front Microbiol       Date:  2020-01-15       Impact factor: 5.640

Review 6.  Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review.

Authors:  Chaohe Zhang; Jiyao Sheng; Guangquan Li; Lihong Zhao; Yicun Wang; Wei Yang; Xiaoxiao Yao; Lihuan Sun; Zhuo Zhang; Ranji Cui
Journal:  Front Pharmacol       Date:  2020-01-15       Impact factor: 5.810

7.  Berberine Suppresses Mice Depression Behaviors and Promotes Hippocampal Neurons Growth Through Regulating the miR-34b-5p/miR-470-5p/BDNF Axis.

Authors:  Yuhua Zhan; Jiyang Han; Jing Xia; Xumei Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-22       Impact factor: 2.570

8.  Oral Probiotics Ameliorate the Behavioral Deficits Induced by Chronic Mild Stress in Mice via the Gut Microbiota-Inflammation Axis.

Authors:  Nannan Li; Qi Wang; Yan Wang; Anji Sun; Yiwei Lin; Ye Jin; Xiaobai Li
Journal:  Front Behav Neurosci       Date:  2018-11-06       Impact factor: 3.558

Review 9.  Pharmacological effects of berberine on mood disorders.

Authors:  Jie Fan; Kun Zhang; Yang Jin; Bingjini Li; Shuohui Gao; Jiaming Zhu; Ranji Cui
Journal:  J Cell Mol Med       Date:  2018-11-18       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.